Cuu Long Pharmaceutical JSC (HOSE:DCL)
23,900
-150 (-0.62%)
At close: Apr 2, 2025
HOSE:DCL Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | 2016 - 2020 |
Net Income | 53,571 | 61,717 | 111,641 | 85,961 | 66,391 | Upgrade
|
Depreciation & Amortization | 37,856 | 38,011 | 38,135 | 34,273 | 28,280 | Upgrade
|
Other Amortization | 401.69 | 267.31 | - | - | - | Upgrade
|
Loss (Gain) From Sale of Assets | - | -8,884 | -25,617 | -43,737 | -71,458 | Upgrade
|
Other Operating Activities | -5,065 | 5,872 | 7,005 | -4,989 | 44,242 | Upgrade
|
Change in Accounts Receivable | 8,662 | -14,709 | -384,124 | -105,671 | 50,453 | Upgrade
|
Change in Inventory | 16,311 | -55,033 | -9,758 | -83,805 | -13,409 | Upgrade
|
Change in Accounts Payable | -27,074 | -1,479 | -161,826 | 214,295 | -12,826 | Upgrade
|
Change in Other Net Operating Assets | -4,850 | -3,233 | -1,001 | 3,380 | 1,693 | Upgrade
|
Operating Cash Flow | 69,813 | 22,530 | -450,071 | 29,437 | 93,366 | Upgrade
|
Operating Cash Flow Growth | 209.86% | - | - | -68.47% | 23.54% | Upgrade
|
Capital Expenditures | -172,850 | -222,874 | -233,028 | -152,612 | -101,948 | Upgrade
|
Sale of Property, Plant & Equipment | - | 370.64 | 250.12 | - | 171.36 | Upgrade
|
Investment in Securities | - | 44,346 | 292,923 | - | - | Upgrade
|
Other Investing Activities | 6,467 | 9,151 | 33,032 | 56,947 | 74,835 | Upgrade
|
Investing Cash Flow | -166,382 | -169,006 | 93,177 | 224,393 | -66,536 | Upgrade
|
Long-Term Debt Issued | 1,199,477 | 973,672 | 1,218,898 | 2,427,584 | 2,014,758 | Upgrade
|
Long-Term Debt Repaid | -1,075,364 | -856,533 | -1,205,603 | -2,702,031 | -2,014,209 | Upgrade
|
Net Debt Issued (Repaid) | 124,113 | 117,138 | 13,295 | -274,447 | 548.85 | Upgrade
|
Issuance of Common Stock | - | - | 355,205 | 20,000 | - | Upgrade
|
Financing Cash Flow | 124,113 | 117,138 | 368,500 | -254,447 | 548.85 | Upgrade
|
Foreign Exchange Rate Adjustments | 8.1 | 2.59 | -8.99 | -5.76 | 0.08 | Upgrade
|
Net Cash Flow | 27,552 | -29,335 | 11,596 | -622.67 | 27,379 | Upgrade
|
Free Cash Flow | -103,037 | -200,343 | -683,099 | -123,174 | -8,582 | Upgrade
|
Free Cash Flow Margin | -7.89% | -17.51% | -67.25% | -17.51% | -1.28% | Upgrade
|
Free Cash Flow Per Share | -1410.67 | -2742.89 | -9736.25 | -2142.18 | -151.01 | Upgrade
|
Cash Interest Paid | 25,437 | 29,199 | 35,991 | 33,237 | 25,943 | Upgrade
|
Cash Income Tax Paid | 14,964 | 12,576 | 25,261 | 33,440 | 14,532 | Upgrade
|
Levered Free Cash Flow | -24,227 | -187,823 | -814,492 | -31,418 | -68,051 | Upgrade
|
Unlevered Free Cash Flow | -8,360 | -168,741 | -789,725 | -8,753 | -47,261 | Upgrade
|
Change in Net Working Capital | -88,838 | 28,350 | 675,010 | -55,347 | 3,533 | Upgrade
|
Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.